BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36539366)

  • 81. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 82. STAT3 regulates SRGN and promotes metastasis of nasopharyngeal carcinoma through the FoxO1-miR-148a-5p-CREB1 axis.
    Wang YL; Ren D; Lu JL; Jiang H; Wei JZ; Lan J; Liu F; Qu SH
    Lab Invest; 2022 Sep; 102(9):919-934. PubMed ID: 35562411
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
    Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
    FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Improved Radiotherapy Sensitivity of Nasopharyngeal Carcinoma Cells by miR-29-3p Targeting COL1A1 3'-UTR.
    Guo Y; Zhai J; Zhang J; Ni C; Zhou H
    Med Sci Monit; 2019 Apr; 25():3161-3169. PubMed ID: 31034464
    [TBL] [Abstract][Full Text] [Related]  

  • 85. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L; Chen L; Luan Q; Kong Q
    J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
    [TBL] [Abstract][Full Text] [Related]  

  • 86. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
    Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
    Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
    [TBL] [Abstract][Full Text] [Related]  

  • 87. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
    Shen Z; Wu Y; He G
    Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
    [TBL] [Abstract][Full Text] [Related]  

  • 89. MicroRNA-195-3p inhibits cyclin dependent kinase 1 to induce radiosensitivity in nasopharyngeal carcinoma.
    Xie F; Xiao W; Tian Y; Lan Y; Zhang C; Bai L
    Bioengineered; 2021 Dec; 12(1):7325-7334. PubMed ID: 34585634
    [TBL] [Abstract][Full Text] [Related]  

  • 90. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
    Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
    J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MicroRNA-205 targets HER3 and suppresses the growth, chemosensitivity and metastasis of human nasopharyngeal carcinoma cells.
    Hao Y; Li J; Zhang H; Guan G; Guo Y
    J BUON; 2020; 25(1):350-356. PubMed ID: 32277654
    [TBL] [Abstract][Full Text] [Related]  

  • 92. miR-574-5p Targets FOXN3 to Regulate the Invasion of Nasopharyngeal Carcinoma Cells via Wnt/β-Catenin Pathway.
    Lin Z; Chen M; Wan Y; Lei L; Ruan H
    Technol Cancer Res Treat; 2020; 19():1533033820971659. PubMed ID: 33317407
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
    Li D; Li X; Fan G; Bian G
    Head Neck; 2022 Jul; 44(7):1631-1645. PubMed ID: 35460538
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
    Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The inhibition of tumor protein p53 by microRNA-151a-3p induced cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Liu H; Cheng Y; Xu Y; Xu H; Lin Z; Fan J; Lang J
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652456
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Knockdown of lncRNA SNHG16 Attenuates the Proliferation and Radioresistance of Nasopharyngeal Carcinoma Cells by Mediating miR-31-5p/SFN Axis.
    Zhang W; Zhou X; Tang Z; Fu L; Zou S; Tang S
    Radiat Res; 2023 Feb; 199(2):124-131. PubMed ID: 36520963
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
    Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.
    Sinnung S; Janvilisri T; Kiatwuthinon P
    Mol Cell Biochem; 2021 Apr; 476(4):1663-1672. PubMed ID: 33423190
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
    Wang X; Wang K; Xiao J; Song Y; Li H
    Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
    [TBL] [Abstract][Full Text] [Related]  

  • 100. CEBPB knockdown sensitizes nasopharyngeal carcinoma cells to cisplatin by promoting the expression of serine protease inhibitor Kazal-type 5.
    Liu H; Huang Q; Lv Y; Dong Y; Song D
    Anticancer Drugs; 2022 Jan; 33(1):e327-e335. PubMed ID: 34387602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.